For GI groups, physician-owned endoscopy centers, IBD infusion suites and hospital-affiliated practices, where one procedure generates four claims and any one of them can fail alone.
Get a free revenue cycle assessmentGastroenterology revenue cycle management is the financial system that runs a GI practice from scheduling through final payment: intent determination, eligibility, prior authorization, charge capture, coding, claim submission, payment posting, denial work and AR follow-up. Medical billing is one stage inside it, starting at the claim; revenue cycle management starts before the patient is seen.
A GI practice does not run one revenue cycle. It runs several that have to agree with each other.
A single colonoscopy can generate a professional claim from the physician, a facility claim from an ambulatory surgery center, an anesthesia claim in base and time units, and a surgical pathology claim per specimen. Those four often belong to four tax IDs, sit in four systems, and are worked by people who never speak.
The structural difference is timing. The financial character of a GI case is decided during the procedure, not before it. A patient arrives for a preventive service expecting no cost, a polyp is found and removed, and the service is now therapeutic. Medicare still waives the deductible and pays 85% of the allowed amount for calendar years 2023 through 2026 under 42 CFR 410.152(l)(5). Those protections attach only if all four claims say what happened, and they are written later by someone who was not in the room.
Then there is the second business. An IBD infusion suite is a buy-and-bill drug operation bolted onto a procedural practice, depending on approvals that expire on a calendar the scheduler cannot see. One lapse writes off a drug already bought, which is why our eligibility and prior authorization team runs that calendar against the infusion schedule, not the claim.
Three or more and the problem is the system, not the staff. A free 30-minute assessment reads your own aging, denial and authorization data back to you with the dollars attached.
Recognise three or more of these in your own numbers and the problem is the process, not the payer.
Get a free assessmentGI revenue cycles are organised by procedure setting and room ownership, and that axis sets the claim count, the payer mix and the authorization burden.
Google is asked the seven steps of the revenue cycle on this search more than almost anything else. Here they are for a GI practice, each with the failure that actually happens.
The case is booked and its character set: screening, surveillance or diagnostic. Failure mode: the answer is recorded nowhere the biller can see, so it is reconstructed from the procedure note later.
Coverage, deductible status, frequency history and plan type are confirmed. Failure mode: nobody checks how long since the last screening, so a case inside a frequency window is performed before anyone knows it will not pay as one.
Approval is obtained for advanced imaging, biologic therapy and repeat procedures. Failure mode: the approval is captured once and never watched, so it expires between infusion doses.
Professional, facility, anesthesia and pathology charges are raised. Failure mode: charge lag runs unmeasured because pathology waits on the report and anesthesia bills from another group, and nobody holds a list of incomplete cases.
The case is coded from the operative report and edits cleared. Failure mode: the professional claim is corrected while the facility claim goes out unchanged, so the two disagree and one is held.
Remittances are posted and checked against the contract. Failure mode: payment posts, the balance zeroes, and nobody compares the allowed amount to the signed schedule.
Denials are grouped by cause and AR worked by age and value. Failure mode: denials are reworked one at a time, so the same causes reappear next month. Our denials and AR recovery team works them by cause, oldest dollars first. Appeals filed by Luxen were overturned 68% of the time, with a median appeal turnaround of 34 days from filing to payer decision, and GI appeals that named the specific payer policy paragraph were overturned at 74% (Luxen client data). All of it depends on filing inside the payer window.
Annual exposure for a three-physician GI group collecting $2.4M a year with a single-room endoscopy suite, from applying the audit rates on the right to that size. Rows are organised by cause.
| Leak point | Codes or rule | What goes wrong | Annual dollars at risk | Luxen audit finding |
|---|---|---|---|---|
| Character of the case decided after the fact | 45378 to 45398, G0105, G0121, modifiers PT and 33 | Nobody owns the decision at booking, so the patient is quoted one thing and billed another | $61,000 | Intent recorded at scheduling in 38% of GI practices reviewed |
| Approvals that expire between doses | J1745, Q5104, 96365 to 96417 | Scheduled against the patient calendar, not the approval calendar | $84,000 | Biologic authorizations had expired before the next dose on 12% of IBD infusion episodes |
| Four claims that never meet again | 00811 to 00813, 88305 | Each worked separately, so one sits denied while the others paid | $47,000 | In 26 of 34 GI practices, three different people or vendors worked the claims from one case |
| Underpayment nobody reads the contract to find | 43200 to 43273, contracted fee schedule | The multiple endoscopy reduction is applied to the wrong base code, the claim pays, and nobody compares the allowed amount to the contract | $39,000 | The average underpaid claim was short by $38 |
| AR that ages past the recovery curve | Timely filing limits, appeal deadlines | Work stops while recovery is still likely | $52,000 | 27% of total AR sat past 90 days in the average practice reviewed; claims past 180 days were recovered at 23% of dollar value |
| Denial follow-up with no owner | All GI claim families | Denials go to whoever has time, so root causes survive | $58,000 | 42% of practice managers said nobody owns denial follow-up full time; the top three denial reasons accounted for 58% of denied dollars |
Total annual exposure at this size: $341,000.
We will tell you which of these leaks is open in your practice, free, in 30 minutes.
Book the reviewTypical comes from named federal files: the 2025 CERT reporting year, the CMS Marketplace Transparency in Coverage file for plan year 2026, the Physician/Supplier Procedure Summary, and SSA section 1842(c). Where no federal file publishes the metric the cell says so. Target is Luxen client data, 38 client practices, January 2024 to June 2026.
| Metric | Definition | Typical | Target |
|---|---|---|---|
| Days in AR | Receivables over average daily charges | Not published federally. Medicare may not pay an electronic claim before day 14, and owes interest after day 30 | 30 to 35 days |
| Net collection rate | Payments over charges less contractual adjustments | Not published federally. CERT measured 8.4% of Part B payments as improper in 2025 | 97% or better |
| Clean claim rate | Claims accepted on first submission | CERT 2025 put minor fee schedule procedures at a 17.6% improper payment rate, with 58.4% of Part B errors from insufficient documentation | 97% or better |
| First-pass denial rate | Claims denied on first adjudication | The Transparency in Coverage file publishes denied claim counts across 10 denial reasons, but counts, not a rate | 6% or lower |
| Cost to collect | Revenue cycle cost over net collections | Not published federally for physician practices | 3% to 6% of collections |
| Denied services rate, gastroenterology | Denied services over services billed | The Physician/Supplier Procedure Summary carries denied services and denied charge fields by HCPCS and specialty code; gastroenterology is code 10. Suppressed small cells make any rate a lower bound | Reviewed monthly by code family |
Typical values come from the named federal source in the table intro. Target values come from Luxen client data.
Prior authorization is the one stage a practice has to win before the service happens. In GI it covers advanced imaging, biologic starts and continuations, repeat endoscopy inside a frequency window, and a growing share of routine procedures under Medicare Advantage.
Under 42 CFR 422.122, impacted payers must send a standard decision within 7 calendar days and an expedited decision within 72 hours. Qualified health plans on the federally facilitated exchanges sit outside those timeframes, though they are covered by the separate requirement to give a specific reason for a denial. Payers must also publish prior authorization metrics on their own websites by March 31 each year, with the Prior Authorization API requirement following on January 1, 2027. A practice that timestamps its own submissions and decisions can hold a payer against a published number.
New York requires a prospective determination within three business days of receiving the necessary information and a concurrent determination within one business day (medical billing in New York). Texas exempts a physician from preauthorization for a service where at least 90% of five or more requests were approved in the evaluation period, for state-regulated commercial plans only (medical billing in Texas).
The operational answer is ownership. 11 staff hours a week go on insurance calls and portal checks in the average practice (Luxen Practice Manager Survey 2026), and that work has to belong to someone who can see the schedule.
This is the mechanic that defines GI. A preventive service becomes a therapeutic one mid-procedure, and four claims, a patient balance and a set of consumer protections all have to follow.
Medicare pays 85% of the allowed amount for calendar years 2023 through 2026 where tissue is removed during a planned screening in the same clinical encounter, rising to 90% for 2027 through 2029 and 100% from January 1, 2030 (42 CFR 410.152(l)(5)). Non-grandfathered commercial plans may charge nothing for the polyp removal (ACA FAQs Part XII), nor for anesthesia the attending provider determines medically appropriate (Part XXVI).
Medicare pays a screening colonoscopy for a high-risk patient after at least 23 months, and for a patient not at high risk after at least 119 months or at least 47 months following a screening flexible sigmoidoscopy, with a minimum age of 45 (42 CFR 410.37). Where a Medicare-covered stool-based test comes back positive, the follow-on colonoscopy has counted as screening since January 1, 2023; for a positive blood-based biomarker test, since January 1, 2025. Neither is subject to those frequency limits. A front desk that cannot see the last screening date is guessing.
Every practice knows the modifier rules. Almost none has a process that settles the character of the case before the patient arrives and carries that decision onto all four claims. Three things make the difference:
Our audit found intent recorded at scheduling in 38% of GI practices reviewed. In the rest, the most expensive decision in the practice was made afterwards by whoever read the note.
Three federal rules change GI cash flow directly, and this results page is silent on all three.
Under 45 CFR 149.420(b), anesthesiology and pathology are ancillary services: furnished out of network at an in-network facility, the balance-billing prohibition applies and no notice-and-consent exception is available. A health care facility here includes an ambulatory surgical center (45 CFR 149.30). For a physician-owned endoscopy center using an outside anesthesia group, the recovery route is independent dispute resolution against the qualifying payment amount, not the patient.
For an uninsured or self-pay patient, a good faith estimate is triggered by scheduling or by any inquiry about cost. Scheduled at least three business days ahead it is due within one business day; at least ten business days ahead, within three; on request, within three (45 CFR 149.610). If billed charges land at least $400 above the estimate, the patient can open patient-provider dispute resolution within 120 calendar days (45 CFR 149.620). An estimate omitting anesthesia and pathology clears that gap easily.
The US Preventive Services Task Force recommends colorectal cancer screening from age 45, graded B for ages 45 to 49 and A for 50 to 75, in its recommendation of May 18, 2021. Medicare's minimum age has been 45 since January 1, 2023. Commercial plan configuration has lagged, so a denial for a 46-year-old screening patient is an appeal with a named authority behind it rather than a write-off. 63% could not name their top three denial reasons (Luxen Practice Manager Survey 2026), which means denials like these are absorbed rather than answered.
The 2026 Luxen GI Front-End Revenue Audit: 9,800 gastroenterology claims within the Luxen claim audit (61,400 claims audited, January 2025 to June 2026) and 34 GI practices within the Luxen billing reviews (410 practice billing reviews, January 2025 to June 2026). We traced each GI claim back to the event that decided its fate, then asked who owned that event.
The claim-ownership count and the share settling a case's character before the patient arrives are findings we have not seen published.
A three-site GI group with an owned two-room endoscopy center, collecting about $2.4M a year, came to us with AR that had stopped moving.
| Measure | At handover | After six months |
|---|---|---|
| Days in AR | 58 | 31 |
| First-pass denial rate | 15.1% | 5.4% |
| AR past 120 days | $214,000 | $38,600 |
| Recovered from aged accounts | $163,400 |
What did most of the work was not a coding change. It was one person put in charge of the four claims each case produces. Reported by the Practice Administrator, three-site gastroenterology group with an owned endoscopy center (Luxen client data).
GI results from the Luxen claim audit and the Luxen billing reviews:
Worked for a three-physician GI group collecting $200,000 a month, $2.4M a year, with an owned single-room endoscopy suite. Every input appears elsewhere on this page.
The median practice had $118,000 in AR older than 120 days when we started: say $70,000 aged 90 to 180 days and $48,000 past 180 days. We recovered 61% of the dollar value of claims aged 90 to 180 days, so $70,000 times 0.61 is $42,700. Claims past 180 days were recovered at 23% of dollar value, so $48,000 times 0.23 is $11,040. Total $53,740, one time.
GI practices entered at a median 51 days in AR against a target band of 30 to 35. Take 51 to 33, a reduction of 18 days. Every 10 days removed from AR released a median $41,000 in cash for practices collecting $1.5M to $3M a year. 18 divided by 10, times $41,000, is $73,800, one time.
The leak table totals $341,000 of annual exposure at this size. The three causes fixed by process rather than negotiation are intent at booking ($61,000), the authorization calendar ($84,000) and denial ownership ($58,000): $203,000 a year.
$53,740 plus $73,800 plus $203,000 is $330,540. At 4% of $2.4M the fee is $96,000, so the net is $234,540 in year one and $107,000 after. The first two lines are one-time cash releases and the third is exposure removed, not revenue booked.
Want this arithmetic run on your own collections and denial rate?
Run my numbersOur fee is 3% to 6% of collections, with nothing charged to start and nothing charged to leave. Nobody else on this search publishes a number. What moves ours inside the band:
Included throughout: certified coders, front-end eligibility and authorization work, submission and scrubbing, posting and reconciliation, denial work and appeals, AR follow-up, underpayment review, and monthly reporting by root cause. Month to month on 30 days notice, with a BAA signed before access.
For the same three-physician group collecting $2.4M a year. The in-house column is what you compute from your own payroll, and the comparison only works if it is fully loaded.
| Line item | In-house | Luxen |
|---|---|---|
| Billing and AR staff, fully loaded | Salary, payroll taxes, benefits, cover and supervision | Included |
| Certified coding | A coder salary, or a per-claim vendor on top | Included, certified coders |
| Practice management and clearinghouse | Paid by the practice | You keep your system, no migration |
| Denial rework | 11 staff hours a week on insurance calls and portal checks | Included, worked by root cause |
| Cover when someone leaves | 34% of practice managers replaced a biller in the past two years | Coverage continues |
| Annual cost at $2.4M collections | Your figure, fully loaded | $72,000 to $144,000 |
Keep it in-house if you have a tenured biller who knows your payers, denial reporting you read, and a succession plan for the day they leave. Compare medical billing companies by state.
People search for a ranked list of RCM companies, but the right partner for a hospital-based GI practice and a physician-owned endoscopy center are not the same company. Score any candidate, ourselves included, out of 25.
| Criterion | What a 5 looks like | What a 1 looks like |
|---|---|---|
| Claim coverage per case | Bills and reconciles all four claims from the same case | Professional claims only |
| Front-end ownership | Owns intent, eligibility, frequency history and authorization tracking before the date of service | Work begins when the charge arrives |
| Denial reporting | Monthly denials by root cause, payer and claim type, with dollars attached | An aging report and a collection percentage |
| Underpayment review | Paid claims checked against the contracted schedule monthly | Not mentioned in the contract |
| Commercial terms | A stated percentage of collections, month to month, no setup or exit fee | A fee basis you cannot restate from memory |
Ask for a sample denial report before you sign. See what full-service medical billing covers.
You have an incumbent, and the risk of switching is a gap in cash flow rather than a gap in service.
We sign the BAA first, then take read access to your existing system. There is no migration and no new software. Expect two weeks before claims are being worked and roughly three weeks before the first recovered payments land.
The first pass goes at your oldest recoverable AR rather than your newest claims, because that is where the recovery curve is steepest and it funds the transition. Your incumbent keeps working claims already submitted while we take everything from an agreed cut-off date. Month to month, no exit fee.
We work inside the systems your GI practice already runs. No migration, no new license, no data conversion.
A GI practice typically runs a specialty EHR and practice management system, a separate endoscopy documentation tool, an ambulatory surgery center system, an anesthesia record and a clearinghouse, and the revenue cycle crosses all of them. Automate in this order:
Scheduling and intent determination, eligibility and verification of benefits, prior authorization and utilization review, charge capture, coding and claim scrubbing, payment posting and reconciliation, then denial root cause analysis and AR follow-up. GI differs at step one, because whether a colonoscopy is screening or diagnostic can change during the procedure and must carry onto four separate claims.
No ranking survives contact with a real practice: the right partner for a hospital-based GI group and for a physician-owned endoscopy center are different companies. Score candidates on five criteria instead. How many of the four claims per case do they bill, do they own the front end before the date of service, is denial reporting by root cause with dollars attached, do they check paid claims against your contract, and is the fee basis one sentence you can repeat.
Longer models split the same work into finer stages: preregistration, registration, insurance verification, prior authorization, charge capture, coding, claim scrubbing, submission, payment posting, denial management, appeals, and collections or write-off. The step count is a modelling choice, not a rule. What matters is whether each stage has a named owner, and 42% of practice managers said nobody owns denial follow-up full time.
Our fee is 3% to 6% of collections, with nothing charged to start or to leave, set by how many of the four claims per case we bill, the authorization workload and the payer mix. For a practice collecting $2.4M a year that is $72,000 to $144,000. Compare it against your own fully loaded billing payroll, not a headline salary.
Expect two weeks before claims are being worked and roughly three weeks before the first recovered payments arrive. Clean claim rate rose from 89.6% to 97.3% in the first 90 days across Luxen client practices. The first pass targets your oldest recoverable AR, so early cash comes from accounts that had stopped moving.
Medical billing is one stage: turning a documented service into a claim and chasing payment. Revenue cycle management owns everything from the moment the case is scheduled, including intent determination, eligibility, frequency history, prior authorization and utilization review, plus contract and underpayment review after payment. In gastroenterology that difference is decisive, because the events determining whether a claim pays happen before the claim exists.
A free 30 minute review of your AR ageing and denial reasons. We tell you what is recoverable and what it would take. No deck, no commitment, no fee.
Book a free revenue cycle assessment%20(1).avif)
